financetom
Business
financetom
/
Business
/
Liberty Global Swings to Q3 Loss, Revenue Rises
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Liberty Global Swings to Q3 Loss, Revenue Rises
Oct 30, 2024 2:48 AM

04:44 PM EDT, 10/29/2024 (MT Newswires) -- Liberty Global ( LBTYA ) reported late Tuesday its Q3 swung to a loss of $3.95 per diluted share from earnings of $1.57 per diluted share a year earlier.

Three analysts polled by Capital IQ expected a loss of $0.56.

Revenue for the quarter ended Sept. 30 was $1.94 billion, up from $1.85 billion a year earlier.

Four analysts polled by Capital IQ expected $1.91 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Standex International Insider Bought Shares Worth $490,000, According to a Recent SEC Filing
Standex International Insider Bought Shares Worth $490,000, According to a Recent SEC Filing
Mar 11, 2026
02:46 PM EST, 02/04/2026 (MT Newswires) -- Andy L Nemeth, Director, on February 04, 2026, executed a purchase for 2,000 shares in Standex International ( SXI ) for $490,000. Following the Form 4 filing with the SEC, Nemeth has control over a total of 8,639 common shares of the company, with 8,639 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/310354/000031035426000002/xslF345X05/form4.xml Price: 242.97,...
India's Lupin Launches Seizure Drug Bioequivalent to Supernus Pharmaceuticals' Trokendi XR
India's Lupin Launches Seizure Drug Bioequivalent to Supernus Pharmaceuticals' Trokendi XR
Mar 11, 2026
02:45 PM EST, 02/04/2026 (MT Newswires) -- India-based pharmaceutical company Lupin said Wednesday it has launched a drug that is bioequivalent to Supernus Pharmaceuticals' ( SUPN ) Trokendi XR in the US. Lupin's Topiramate extended-release capsules were launched after the US Food and Drug Administration approved its Abbreviated New Drug Application, the company said. The drug is approved for partial-onset...
Commercial Metals Insider Sold Shares Worth $2,003,249, According to a Recent SEC Filing
Commercial Metals Insider Sold Shares Worth $2,003,249, According to a Recent SEC Filing
Mar 11, 2026
02:45 PM EST, 02/04/2026 (MT Newswires) -- Jennifer J Durbin, Former Chief Human Resources and Communications Officer, on February 03, 2026, sold 25,050 shares in Commercial Metals ( CMC ) for $2,003,249. Following the Form 4 filing with the SEC, Durbin has control over a total of 52,880 common shares of the company, with 52,880 shares held directly. SEC Filing:...
Fredonia Mining Up 5% As Closes Oversubscribed C$7M Best Efforts Private Placement
Fredonia Mining Up 5% As Closes Oversubscribed C$7M Best Efforts Private Placement
Mar 11, 2026
02:45 PM EST, 02/04/2026 (MT Newswires) -- Fredonia Mining ( FREDF ) was up more than 5% at last look on Wednesday after closing its best efforts private placement, pursuant to which it issued an aggregate of 17.5 million units of the company at a price of C$0.40 each for total gross proceeds of C$7 million. A statement noted that...
Copyright 2023-2026 - www.financetom.com All Rights Reserved